Latest Breaking News On - High case - Page 7 : comparemela.com

Nevro Reports First Quarter 2021 Financial Results and Updates 2021 Guidance News provided by Share this article Share this article REDWOOD CITY, Calif., May 5, 2021 /PRNewswire/  Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today reported its financial results for the first quarter ended March 31, 2021 and provided updated 2021 guidance. First Quarter and Recent Highlights First Quarter 2021 Worldwide Revenue of $88.6 Million; Increase of 1% Compared to Prior Year and Increase of 8% Compared to 2019 First Quarter 2021 Net Loss from Operations of $22.5 Million; First Quarter 2021 Non-GAAP Adjusted EBITDA of Negative $6.6 Million Updates Full Year 2021 Revenue Guidance to $440 Million to $450 Million

United statesRedwood cityD keith grossmanExchange commissionNevro corpPrior yearFirst quarterFull yearFirst major omnia upgradeNew trial stimulator modulePainful diabetic neuropathyDemonstrated significantly improvedSustained outcomesComprehensive new brand identity combining nevroInnovative technologiesAdvanced therapies